Watch out for a rash of articles which slant the truth.
These writers are 'paid' to put together stories which always have a slant to them. Most of the time
it's not so much what they put into the piece, but what they leave out, i.e., facts, figures, competitive analysis, and you know the drill. OREX is paying for articles that try and keep them visible and a viable competitor, knowing full well they are most likely not going to have a product on the market for a year and a half. VVUS and their HF buddies are attempting to pump up their sales numbers by using only percentages of increase. Yes, last month you sold 1000 pills and this month you sold 1500 and you've increased your sales by 50%. All the while knowing their product is bombing. Mostly, it's these forces know ARNA has a huge advantage with a major partner, money in the bank with more coming, launch any day now with DEA sign-off, and new counties and partners on the way. They are scared sheetless that they will be buried once Belviq hits the street. There is all kinds of posturing, innuendo, half-truths, and plain out lies being floated. As the window narrows, the desperation gets more intense and drives this behavior. Do your own DD, and arrive at the truth. JMO
True, and these articles are rarely much use... But I did find myself agreeing with the SA article by Spencer Osborne on price fluctuations, just posted. I thought it was pretty much on the money, so to speak...